Perfil
Rebecca Lin is currently a Director at Shanghai Rarestone Health Tech Group Co., Ltd. and a Senior Partner & Co Head at Eight Roads Capital Advisors (CHINA) since 2021.
Education includes an undergraduate degree from Shenzhen University conferred in 1994 and an MBA from The Wharton School of the University of Pennsylvania conferred in 2000.
Cargos activos de Rebecca Lin
| Empresas | Cargo | Inicio |
|---|---|---|
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Inversor de Capital Privado | 01/06/2007 |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Director/Miembro de la Junta | - |
Formación de Rebecca Lin.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Shenzhen University
Shenzhen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Health Technology |
- Bolsa de valores
- Insiders
- Rebecca Lin
















